A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent unintended consequences.

Gill Riley, who wasn't obese, regrets taking unprescribed weight-loss medication she purchased from a friend 'to be skinny' ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.